New York (CNN Business) The stock market is like that old slogan for Timex watches. It takes a licking but keeps on ticking. Sure, it's been a rocky start to the year on Wall Street following a stellar 2021. The Dow is down about 1% and the S&P 500 has fallen 2%. Trading has been volatile. But the Dow and S&P are still each just 3% below their all-time highs. Tech stocks have had a bit more of a wild ride. The Nasdaq is down 5% in 2022 and nearly 8% under its peak, putting it closer to a 10% drop known as a correction. Yet every time it looks like stocks could be heading for an even steeper drop, investors come rushing back in to buy the dips. Traders have so far mostly shrugged off temporary concerns about inflation and the Federal Reserve getting ready to raise interest rates , as well as fears over the impact that the Omicron variant of Covid-19 may have on the economy. Earnings growth has remained strong in spite of these … [Read more...] about Here’s what could rattle the stock market this year
Asx 200 tech stocks
Share prices of Rivian Automotive ( NASDAQ:RIVN ) briefly fell to $75.13 per share on Friday before closing the session at $79.95 per share. It was the first time Rivian stock dipped below its initial public offering (IPO) price of $78 per share. The sell-off marks over a 55% drawdown from the stock's all-time intraday high of $179.47 per share set on Nov. 16, 2021. Here are arguments for and against buying the electric vehicle (EV) stock now. Image source: Rivian Automotive. Take advantage of inefficient markets Howard Smith : Markets aren't always efficient, and that's how investors can gain an advantage. While Rivian shares have dropped recently in concert with many high-growth tech names, one of the biggest dips came with the news that Amazon ( NASDAQ:AMZN ) was starting a partnership with Chrysler parent Stellantis ( NYSE:STLA ) to supplement its supply of electric delivery vans. Prior to this news, investors only knew that Amazon -- an early … [Read more...] about Rivian Stock Just Fell Below its IPO Price of $78 Per Share: Time to Buy?
Share to Twitter Share to Linkedin Bitcoin and cryptocurrency prices have bounced back following a sell-off that wiped around $1 trillion from the combined crypto market— and after one closely-watched investor called the market bottom . Subscribe now to Forbes' CryptoAsset & Blockchain Advisor and discover hot new NFT and crypto blockbusters poised for 1,000% gains The bitcoin price, dropping this week under $40,000 per bitcoin for the first time since September has climbed to around $43,000—a rise of 5% over the last three days. The ethereum price has also rallied, adding almost 10% and boosting the price of its rivals Binance's BNB, solana and cardano. ADVERTISEMENT Now, legendary investor Bill Miller has revealed 50% of his net worth is held in bitcoin and related crypto investments—branding bitcoin an "insurance policy against a financial catastrophe." Sign up now for the free CryptoCodex —A daily newsletter for the … [Read more...] about Legendary Investor Reveals Huge Bitcoin Bet As The Price Of Ethereum, BNB, Solana, Cardano And XRP Suddenly Soar
Share to Twitter Share to Linkedin When the University of Maryland Medical Center announced the first successful transplant of a heart that was grown in a genetically altered pig earlier this week, it notched a big win for one of America’s wealthiest self-made women. Revivicor, a subsidiary of United Therapeutics–founded and led by Martine Rothblatt – supplied the heart that made the surgery possible. A former communications satellite lawyer who went on to cofound Sirius Satellite Radio, Rothblatt, 67, has been on a long journey to biotechnology success. United Therapeutics, which is listed on the Nasdaq, has been experimenting with pig cloning and genetic modification in recent years, with the goal of creating organs that the human body won’t reject during transplant operations. Through its Revivicor arm, the company has worked to manufacture the engineered pig organs, such as xenokidneys and xenohearts, to be transplanted to patients with end-stage … [Read more...] about One Of America’s Richest Self-Made Women, Martine Rothblatt, Played Key Role In Week’s Historic Heart Transplant